- Home
- LEE vs SGMO Comparison
LEE vs SGMO Comparison
Compare LEE & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LEE | SGMO |
|---|---|---|
| Founded | 1890 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Newspapers/Magazines | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.1M | 141.2M |
| IPO Year | 2025 | 2000 |
Fundamental Metrics
Financial Performance| Metric | LEE | SGMO |
|---|---|---|
| Price | $8.72 | $0.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 34.3K | ★ 6.6M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.20 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $543,955,000.00 | $36,567,000.00 |
| Revenue This Year | $5.48 | $107.15 |
| Revenue Next Year | N/A | $76.44 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 88.60 |
| 52 Week Low | $3.34 | $0.21 |
| 52 Week High | $9.97 | $0.84 |
Technical Indicators
Market Signals| Indicator | LEE | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 57.35 | 41.78 |
| Support Level | $8.07 | $0.21 |
| Resistance Level | $9.40 | $0.55 |
| Average True Range (ATR) | 0.47 | 0.03 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 83.50 | 47.13 |
Price Performance
Historical ComparisonAbout LEE Lee Enterprises Incorporated
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.